SLARD 2026: Plasma-Rich Plasma Does Not Improve Pain or Function in Lateral Epicondylitis vs Placebo .
OrthoEvidence Journal (OE Journal) - ACE Report
Epub Ahead of Print
6 randomized controlled trials involving 355 patients with lateral epicondylitis were included in this systematic review and meta-analysis comparing platelet-rich plasma (PRP) vs placebo. Pooled outcomes included pain, function, quality of life, grip strength, adverse effects, and treatment tolerability. The pooled analysis demonstrated no significant differences between PRP and placebo for pain relief at 4, 8–12, or 24–26 weeks, and no significant improvements in functional outcomes at any assessed time point. Adverse event rates were also similar between groups. Overall, the findings suggest that PRP does not provide clinically meaningful benefits over placebo for lateral epicondylitis and do not support its routine use for this condition.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
